Literature DB >> 26242249

An EQ-5D-5L value set based on Uruguayan population preferences.

Federico Augustovski1,2, Lucila Rey-Ares1, Vilma Irazola1, Osvaldo Ulises Garay1, Oscar Gianneo3, Graciela Fernández3, Marcelo Morales3, Luz Gibbons1, Juan Manuel Ramos-Goñi4,5.   

Abstract

PURPOSE: To derive a value set from Uruguayan general population using the EQ-5D-5L questionnaire and report population norms.
METHODS: General population individuals were randomly assigned to value 10 health states using composite time trade off and 7 pairs of health states through discrete choice experiments. A stratified sampling with quotas by location, gender, age and socio-economic status was used to respect the Uruguayan population structure. Trained interviewers conducted face-to-face interviews. The EuroQol valuation technology was used to administer the protocol as well as to collect the data. OLS and maximum likelihood robust regression models with or without interactions were tested.
RESULTS: We included 794 respondents between 20 and 83 years. Their characteristics were broadly similar to the Uruguayan population. The main effects robust model was chosen to derive social values. Values ranged from -0.264 to 1. States with a misery index = 6 had a mean predicted value of 0.965. When comparing the Uruguayan population with the Argentinian EQ-5D-5L crosswalk value set, the prediction for states which differed from full health only in having one of the dimensions at level 2 were about 0.05 higher in Uruguay. The mean index value, using the selected Uruguayan EQ-5D-5L value set, for the general population in Uruguay was 0.895. In general, older people had worse values and males had slightly better values than females.
CONCLUSION: We derived the EQ-5D-5L Uruguayan value set, the first in Latin America. These results will help inform decision-making using economic evaluations for resource allocation decisions.

Entities:  

Keywords:  EuroQol; Preferences; Quality of life; Uruguay; Value set

Mesh:

Year:  2015        PMID: 26242249     DOI: 10.1007/s11136-015-1086-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  21 in total

1.  EuroQol--a new facility for the measurement of health-related quality of life.

Authors: 
Journal:  Health Policy       Date:  1990-12       Impact factor: 2.980

2.  Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets.

Authors:  Ben van Hout; M F Janssen; You-Shan Feng; Thomas Kohlmann; Jan Busschbach; Dominik Golicki; Andrew Lloyd; Luciana Scalone; Paul Kind; A Simon Pickard
Journal:  Value Health       Date:  2012-05-24       Impact factor: 5.725

3.  A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol.

Authors:  Mark Oppe; Nancy J Devlin; Ben van Hout; Paul F M Krabbe; Frank de Charro
Journal:  Value Health       Date:  2014-06       Impact factor: 5.725

4.  The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty.

Authors:  Meridith E Greene; Kevin A Rader; Göran Garellick; Henrik Malchau; Andrew A Freiberg; Ola Rolfson
Journal:  Clin Orthop Relat Res       Date:  2015-11       Impact factor: 4.176

5.  Lead versus lag-time trade-off variants: does it make any difference?

Authors:  Federico Augustovski; Lucila Rey-Ares; Vilma Irazola; Mark Oppe; Nancy J Devlin
Journal:  Eur J Health Econ       Date:  2013-07

6.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

Authors:  M Herdman; C Gudex; A Lloyd; Mf Janssen; P Kind; D Parkin; G Bonsel; X Badia
Journal:  Qual Life Res       Date:  2011-04-09       Impact factor: 4.147

7.  Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.

Authors:  Juntana Pattanaphesaj; Montarat Thavorncharoensap
Journal:  Health Qual Life Outcomes       Date:  2015-02-06       Impact factor: 3.186

8.  The development of new research methods for the valuation of EQ-5D-5L.

Authors:  Nancy J Devlin; Paul F M Krabbe
Journal:  Eur J Health Econ       Date:  2013-07

9.  Validity of EQ-5D-5L in stroke.

Authors:  Dominik Golicki; Maciej Niewada; Julia Buczek; Anna Karlińska; Adam Kobayashi; M F Janssen; A Simon Pickard
Journal:  Qual Life Res       Date:  2014-10-28       Impact factor: 4.147

10.  Multinational evidence of the applicability and robustness of discrete choice modeling for deriving EQ-5D-5L health-state values.

Authors:  Paul F M Krabbe; Nancy J Devlin; Elly A Stolk; Koonal K Shah; Mark Oppe; Ben van Hout; Elise H Quik; A Simon Pickard; Feng Xie
Journal:  Med Care       Date:  2014-11       Impact factor: 2.983

View more
  38 in total

1.  Feasibility, comparability, and reliability of the standard gamble compared with the rating scale and time trade-off techniques in Korean population.

Authors:  Seon-Ha Kim; Sang-Il Lee; Min-Woo Jo
Journal:  Qual Life Res       Date:  2017-08-11       Impact factor: 4.147

2.  Smoking, health-related quality of life and economic evaluation.

Authors:  Ángel López-Nicolás; Marta Trapero-Bertran; Celia Muñoz
Journal:  Eur J Health Econ       Date:  2017-07-26

3.  Do country-specific preference weights matter in the choice of mapping algorithms? The case of mapping the Diabetes-39 onto eight country-specific EQ-5D-5L value sets.

Authors:  Admassu N Lamu; Gang Chen; Thor Gamst-Klaussen; Jan Abel Olsen
Journal:  Qual Life Res       Date:  2018-03-22       Impact factor: 4.147

4.  A Systematic Review of the Methodologies and Modelling Approaches Used to Generate International EQ-5D-5L Value Sets.

Authors:  Donna Rowen; Clara Mukuria; Emily McDool
Journal:  Pharmacoeconomics       Date:  2022-07-13       Impact factor: 4.558

5.  The Danish EQ-5D-5L Value Set: A Hybrid Model Using cTTO and DCE Data.

Authors:  Cathrine Elgaard Jensen; Sabrina Storgaard Sørensen; Claire Gudex; Morten Berg Jensen; Kjeld Møller Pedersen; Lars Holger Ehlers
Journal:  Appl Health Econ Health Policy       Date:  2021-02-02       Impact factor: 2.561

6.  Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis.

Authors:  Pablo Manuel Bianculli; Lucile Bellier; Ignacio Olivera Mangado; Carlos Grau Pérez; Gustavo Mieres; Luis Lazarov; Audrey Petitjean; Hugo Dibarboure; Juan Guillermo Lopez
Journal:  Hum Vaccin Immunother       Date:  2022-03-28       Impact factor: 4.526

7.  Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis.

Authors:  Mónica Hernández-Alava; Stephen Pudney
Journal:  J Health Econ       Date:  2017-07-04       Impact factor: 3.883

8.  The Indonesian EQ-5D-5L Value Set.

Authors:  Fredrick Dermawan Purba; Joke A M Hunfeld; Aulia Iskandarsyah; Titi Sahidah Fitriana; Sawitri Supardi Sadarjoen; Juan Manuel Ramos-Goñi; Jan Passchier; Jan J V Busschbach
Journal:  Pharmacoeconomics       Date:  2017-11       Impact factor: 4.981

9.  The impact of symptoms and comorbidity on health utility scores and health-related quality of life in small cell lung cancer using real world data.

Authors:  Geoffrey Liu; Grainne M O'Kane; Ali Vedadi; Sharara Shakik; M Catherine Brown; Benjamin H Lok; Frances A Shepherd; Natasha B Leighl; Adrian Sacher; Penelope A Bradbury; Wei Xu
Journal:  Qual Life Res       Date:  2020-08-26       Impact factor: 3.440

10.  Assessing the Use of a Feedback Module to Model EQ-5D-5L Health States Values in Hong Kong.

Authors:  Eliza L Y Wong; Juan Manuel Ramos-Goñi; Annie W L Cheung; Amy Y K Wong; Oliver Rivero-Arias
Journal:  Patient       Date:  2018-04       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.